Arnatar Therapeutics Inc. is a San Diego-based biotechnology company founded in 2021 by Dr. Xuehai Liang and Dr. Yanfeng Wang. The company specializes in developing RNA-based therapies using its proprietary DARGER™ platform, which combines gene silencing with the ability to upregulate protein expression.